These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34639113)

  • 1. The Phenoxyalkyltriazine Antagonists for 5-HT
    Sudoł S; Cios A; Jastrzębska-Więsek M; Honkisz-Orzechowska E; Mordyl B; Wilczyńska-Zawal N; Satała G; Kucwaj-Brysz K; Partyka A; Latacz G; Olejarz-Maciej A; Wesołowska A; Handzlik J
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HT
    Latacz G; Lubelska A; Jastrzębska-Więsek M; Partyka A; Marć MA; Satała G; Wilczyńska D; Kotańska M; Więcek M; Kamińska K; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are the Hydantoin-1,3,5-triazine 5-HT
    Lubelska A; Latacz G; Jastrzębska-Więsek M; Kotańska M; Kurczab R; Partyka A; Marć MA; Wilczyńska D; Doroz-Płonka A; Łażewska D; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31817628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exit beyond the pharmacophore model for 5-HT
    Kucwaj-Brysz K; Ali W; Kurczab R; Sudoł-Tałaj S; Wilczyńska-Zawal N; Jastrzębska-Więsek M; Satała G; Mordyl B; Żesławska E; Agnieszka-Olejarz-Maciej ; Czarnota K; Latacz G; Partyka A; Wesołowska A; Nitek W; Handzlik J
    Bioorg Chem; 2022 Apr; 121():105695. PubMed ID: 35228010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The computer-aided discovery of novel family of the 5-HT
    Łażewska D; Kurczab R; Więcek M; Kamińska K; Satała G; Jastrzębska-Więsek M; Partyka A; Bojarski AJ; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Eur J Med Chem; 2017 Jul; 135():117-124. PubMed ID: 28441580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorine substituents and linker topology as factors of 5-HT
    Sudoł S; Kucwaj-Brysz K; Kurczab R; Wilczyńska N; Jastrzębska-Więsek M; Satała G; Latacz G; Głuch-Lutwin M; Mordyl B; Żesławska E; Nitek W; Partyka A; Buzun K; Doroz-Płonka A; Wesołowska A; Bielawska A; Handzlik J
    Eur J Med Chem; 2020 Oct; 203():112529. PubMed ID: 32693296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Triazine Derivatives as Serotonin 5-HT
    Łażewska D; Więcek M; Satała G; Chałupnik P; Żesławska E; Honkisz-Orzechowska E; Tarasek M; Latacz G; Nitek W; Szymańska E; Handzlik J
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new serotonin 5-HT
    González-Vera JA; Medina RA; Martín-Fontecha M; Gonzalez A; de la Fuente T; Vázquez-Villa H; García-Cárceles J; Botta J; McCormick PJ; Benhamú B; Pardo L; López-Rodríguez ML
    Sci Rep; 2017 Jan; 7():41293. PubMed ID: 28117458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer's Disease.
    Grychowska K; Satała G; Kos T; Partyka A; Colacino E; Chaumont-Dubel S; Bantreil X; Wesołowska A; Pawłowski M; Martinez J; Marin P; Subra G; Bojarski AJ; Lamaty F; Popik P; Zajdel P
    ACS Chem Neurosci; 2016 Jul; 7(7):972-83. PubMed ID: 27100049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT6 receptor antagonists: prospects for the treatment of cognitive disorders including dementia.
    Johnson CN; Ahmed M; Miller ND
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):642-54. PubMed ID: 18729016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and computer-aided SAR studies for derivatives of phenoxyalkyl-1,3,5-triazine as the new potent ligands for serotonin receptors 5-HT
    Ali W; Więcek M; Łażewska D; Kurczab R; Jastrzębska-Więsek M; Satała G; Kucwaj-Brysz K; Lubelska A; Głuch-Lutwin M; Mordyl B; Siwek A; Nasim MJ; Partyka A; Sudoł S; Latacz G; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Eur J Med Chem; 2019 Sep; 178():740-751. PubMed ID: 31229876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT
    Czarnota-Łydka K; Sudoł-Tałaj S; Kucwaj-Brysz K; Kurczab R; Satała G; de Candia M; Samarelli F; Altomare CD; Carocci A; Barbarossa A; Żesławska E; Głuch-Lutwin M; Mordyl B; Kubacka M; Wilczyńska-Zawal N; Jastrzębska-Więsek M; Partyka A; Khan N; Więcek M; Nitek W; Honkisz-Orzechowska E; Latacz G; Wesołowska A; Carrieri A; Handzlik J
    Eur J Med Chem; 2023 Nov; 259():115695. PubMed ID: 37567058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and computer-aided analysis of the role of linker for novel ligands of the 5-HT
    Łażewska D; Kurczab R; Więcek M; Satała G; Kieć-Kononowicz K; Handzlik J
    Bioorg Chem; 2019 Mar; 84():319-325. PubMed ID: 30530073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.
    Benhamú B; Martín-Fontecha M; Vázquez-Villa H; Pardo L; López-Rodríguez ML
    J Med Chem; 2014 Sep; 57(17):7160-81. PubMed ID: 24850589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophils adhesion assay as a tool for phenotypic drug screening - The pharmacology of 1,3,5 - Triazine and 1H-indole like derivatives against the human histamine H
    Grosicki M; Adami M; Micheloni C; Głuch-Lutwin M; Siwek A; Latacz G; Łażewska D; Więcek M; Reiner-Link D; Stark H; Chlopicki S; Kieć-Kononowicz K
    Eur J Pharmacol; 2021 Jan; 890():173611. PubMed ID: 33017589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Cyclic amine-3-arylsulfonylindazoles as novel 5-HT6 receptor antagonists.
    Haydar SN; Yun H; Andrae PM; Mattes J; Zhang J; Kramer A; Smith DL; Huselton C; Graf R; Aschmies S; Schechter LE; Comery TA; Robichaud AJ
    J Med Chem; 2010 Mar; 53(6):2521-7. PubMed ID: 20170099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The procognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia.
    Nikiforuk A
    Rev Neurosci; 2014; 25(3):367-82. PubMed ID: 24501158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
    Kołaczkowski M; Marcinkowska M; Bucki A; Śniecikowska J; Pawłowski M; Kazek G; Siwek A; Jastrzębska-Więsek M; Partyka A; Wasik A; Wesołowska A; Mierzejewski P; Bienkowski P
    Eur J Med Chem; 2015 Mar; 92():221-35. PubMed ID: 25557493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin 5-HT
    Ferrero H; Solas M; Francis PT; Ramirez MJ
    CNS Drugs; 2017 Jan; 31(1):19-32. PubMed ID: 27914038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease.
    Geldenhuys WJ; Van der Schyf CJ
    Expert Rev Neurother; 2009 Jul; 9(7):1073-85. PubMed ID: 19589055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.